Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05726682
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogenic Stem Cell Transplantation
Sanofi
Not applicableStudy completedNCT07739979
What this trial is testing

Radiological Outcome of Bony Fusion After Single Level Anterior Cervical Discectomy and Fusion Using Iliac Crest Graft vs. Polyetheretherketone Cage in Cervical Spondylosis

Who this might be right for
Cervical Spondylopathy
Services Hospital, Lahore 42
Not applicableStudy completedNCT01033188
What this trial is testing

Double Bundle Anterior Cruciate Ligament Reconstruction

Who this might be right for
Knee Outcome, Subjective
Oslo University Hospital 120
Post-approval studies (Phase 4)Looking for participantsNCT05072262
What this trial is testing

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)

Who this might be right for
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)Descemet Membrane Endothelial Keratoplasty (DMEK)
Oslo University Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03399773
What this trial is testing

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Fred Hutchinson Cancer Center 31
Post-approval studies (Phase 4)Active Not RecruitingNCT03560310
What this trial is testing

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Vastra Gotaland Region 2,201
Testing effectiveness (Phase 2)Ended earlyNCT04111497
What this trial is testing

Glasdegib for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseFasciitis
Fred Hutchinson Cancer Center 15
Not applicableEnded earlyNCT04534010
What this trial is testing

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

Who this might be right for
Breast Cancer
Stanford University 6
Testing effectiveness (Phase 2)Study completedNCT00987480
What this trial is testing

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Who this might be right for
Aplastic AnemiaLeukemiaMyelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03292861
What this trial is testing

The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients

Who this might be right for
Heart Transplantation
Cedars-Sinai Medical Center 60
Post-approval studies (Phase 4)Study completedNCT00189150
What this trial is testing

Pharmacokinetics of Mmf and Valganciclovir

Who this might be right for
Kidney Transplant RecipientHeart Transplant Recipient
University of Michigan 16
Not applicableActive Not RecruitingNCT05864560
What this trial is testing

Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up

Who this might be right for
Abdominal Aortic Aneurysm
Lifetech Scientific (Shenzhen) Co., Ltd. 164
Not applicableUnknownNCT04605120
What this trial is testing

Allogeinic Bone Paste

Who this might be right for
Cervical FusionCervical Disc DegenerationSpinal Fusion
Biobank 50
Early research (Phase 1)Study completedNCT02560220
What this trial is testing

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14
Testing effectiveness (Phase 2)Ended earlyNCT04941404
What this trial is testing

TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Glucocorticoid-Refractory aGVHD
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 13
Testing effectiveness (Phase 2)Study completedNCT02153268
What this trial is testing

Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration

Who this might be right for
Bone Void in the Maxillofacial Area
BonusBio Group Ltd 11
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Not applicableStudy completedNCT06080490
What this trial is testing

Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

Who this might be right for
Graft Vs Host DiseaseTransplant FailureStem Cell Transplant Complications
University of Pisa 125
Large-scale testing (Phase 3)Study completedNCT04421274
What this trial is testing

Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction

Who this might be right for
Myocardial Infarction
Affiliated Hospital of North Sichuan Medical College 43
Testing effectiveness (Phase 2)WithdrawnNCT04334174
What this trial is testing

Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas

Who this might be right for
T Cell Lymphoma
University of Kansas Medical Center
Next Page